Medpace Director Brian T. Carley Acquires 36 Shares via RSU Vesting
Medpace Holdings, Inc.
Subscribe to track MEDP
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 4 Filing: Medpace Holdings, Inc. ($MEDP) Insider: Brian T. Carley (Director) Transaction Date: 2026-09-30 Action: Conversion (Code M) of 36 Restricted Stock Units into Common Stock at $0/share. Post-Transaction Holdings: 27,861 shares Significance: Low (Routine scheduled vesting)
Comprehensive Analysis
Executive Summary
On October 2, 2026, Medpace Holdings, Inc. ($MEDP) director Brian T. Carley reported the acquisition of 36 shares of common stock on September 30, 2026. This acquisition was the result of a routine restricted stock unit (RSU) vesting event.
Transaction Highlights
- Security: Common Stock
- Transaction Code: M (Exercise or conversion of derivative security exempted pursuant to Rule 16b-3)
- Shares Acquired: 36 shares
- Transaction Price: $0.00 per share (conversion of RSUs)
- Post-Transaction Direct Ownership: 27,861 shares of Common Stock and 35 remaining RSUs
Context and Market Significance
This filing reflects the third installment of an RSU grant awarded on November 28, 2025, which vests quarterly over 2026. Because this transaction represents a standard equity compensation vesting rather than an open-market purchase or disposition, it carries low informational impact regarding insider sentiment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.